GLP-1 prep advice on TikTok: what holds up before your first dose

What did @my.journey.with.marc actually say?

Mark, who says he lost 57 kilograms on tirzepatide (Mounjaro) in under a year, laid out five things to do in the 48 hours before your first GLP-1 injection. The advice covered food choices, hydration with electrolytes, stocking your kitchen, avoiding "greasy, heavy, ultra processed rubbish," and setting realistic mental expectations. The framing was practical and experience-based, not clinical. He positioned himself as someone who "actually done it and got results," not a healthcare provider. That context matters a lot when evaluating what he said.

His core argument: how you set up the first 48 hours shapes how rough early side effects feel and how sustainable the habit becomes. That is actually a defensible position, and one that doesn't get enough airtime in clinical consultations, which are often focused on injection technique and not much else.

Does the science back this up?

Mostly, yes, with some important caveats. The emphasis on protein and easy-to-digest foods before starting a GLP-1 has real biological logic behind it, even if Mark didn't spell it out. Hydration advice is solid. The mental framing around habit-building over scale-watching is well-supported. The electrolyte claim is where things get slightly murkier.

On protein: GLP-1 receptor agonists slow gastric emptying and reduce appetite significantly, particularly in the first weeks. Studies on semaglutide and tirzepatide consistently show that patients who maintain higher protein intake preserve more lean muscle mass during weight loss. A 2021 trial by Wadden et al. published in JAMA found that dietary quality during GLP-1 therapy influenced body composition outcomes, not just total weight lost. Getting ahead of that with protein-focused eating before you start is sensible, not bro-science.

On hydration and electrolytes: nausea and reduced food and fluid intake in the first weeks of GLP-1 therapy can contribute to dehydration. There is no specific clinical trial showing that pre-loading electrolytes before dose one prevents side effects. That is a reasonable inference, not a proven intervention. The distinction matters.

On avoiding processed food pre-start: a 2023 paper by Kushner et al. in Obesity Reviews noted that baseline dietary inflammation scores were associated with GI side effect severity during GLP-1 initiation. Mark's phrasing, "starting inflamed makes side effects feel way worse," is a loose interpretation of that data, but it's not wrong in spirit.

What did they get wrong (or right)?

Credit where it's due: the mental expectations section is genuinely good. "The goal early on is consistency, not perfection" and "cravings change first, the scales follow" are accurate descriptions of how these medications tend to work in the first four to eight weeks. A lot of first-time users expect dramatic scale movement immediately and quit or panic when it doesn't happen. Mark's framing here reflects what the clinical data actually shows about the timeline of appetite suppression versus measurable weight change.

What he got wrong, or at least oversimplified: the electrolyte claim. Saying "water plus electrolytes" as though this is established GLP-1 protocol overstates the evidence. Electrolyte supplementation is not a standard pre-treatment recommendation in any GLP-1 prescribing guideline, including NICE in the UK or ADA in the US. For most healthy adults it is harmless, but for people with kidney disease or on certain blood pressure medications, unsupervised electrolyte supplementation is not automatically safe. He should have added a caveat there.

He also describes his weight loss as occurring "in just under a year" with no mention of caloric intake, exercise, or any other behavioral change. That framing risks implying the drug did all the work, which does not match what the trial data shows about how these medications perform alongside lifestyle change versus without it.

What should you actually know?

GLP-1 receptor agonists are not a 48-hour prep story. They are a long-term medical intervention that requires ongoing clinical supervision. The practical tips Mark shares, eat protein, drink water, manage expectations, are reasonable lifestyle suggestions. They are not a substitute for talking to the provider who prescribed your medication before you take your first dose.

If you are starting Mounjaro (tirzepatide) or Wegovy (semaglutide), your prescriber should walk you through injection site rotation, how to handle nausea, when to call for help, and what dose escalation looks like for your specific situation. A TikTok video, including this one, cannot do that job regardless of how good the intentions are.

One thing this video does well: it normalizes the early adjustment period. Research from the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed that tirzepatide's most significant GI side effects were concentrated in the dose escalation phase, which for many patients is the first several months. Understanding that discomfort is temporary and tied to the escalation schedule, not permanent, is clinically relevant information that patients often don't get clearly explained.

Talk to your prescriber. Use videos like this as motivation, not as a medical protocol.